The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era
Author:
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy,Rheumatology
Link
https://link.springer.com/content/pdf/10.1007/s00296-022-05136-x.pdf
Reference209 articles.
1. Keffer J, Probert L, Cazlaris H et al (1991) Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 10:4025–4031
2. Schett G, McInnes IB, Neurath MF (2021) Reframing immune-mediated inflammatory diseases through signature cytokine hubs. N Engl J Med 385:628–639. https://doi.org/10.1056/NEJMra1909094
3. Sfikakis PP (2010) The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Curr Dir Autoimmun 11:180–210. https://doi.org/10.1159/000289205
4. Sanchez-Cano D, Callejas-Rubio JL, Ruiz-Villaverde R et al (2013) Off-label uses of anti-TNF therapy in three frequent disorders: Behcet’s disease, sarcoidosis, and noninfectious uveitis. Mediators Inflamm 2013:286857. https://doi.org/10.1155/2013/286857
5. Shuai ZQ, Zhang CX, Shuai ZW, et al (2021) Efficacy and safety of biological agents in the treatment of patients with Takayasu arteritis: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 25: 250–62. https://doi.org/10.26355/eurrev_202101_24391.
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tumor Necrosis Alpha (TNF-α) Antagonists Used in Chronic Inflammatory Rheumatic Diseases: Risks and their Minimization Measures;Current Drug Safety;2024-11
2. Histoplasmosis around the world: A global perspective on the presentation, virulence factors, and treatment of histoplasmosis;The American Journal of the Medical Sciences;2024-10
3. Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons—A Comprehensive Review;International Journal of Molecular Sciences;2024-09-07
4. Inflammatory disease status and response to TNF blockade are associated with mechanisms of endotoxin tolerance;Journal of Autoimmunity;2024-09
5. Real-life data of etanercept efficacy and safety in juvenile idiopathic arthritis: a 24-month retrospective study at a single center;Expert Opinion on Biological Therapy;2024-08-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3